Diksha Nagpal

Ms. Diksha Nagpal

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 October 2023 in Journal of Drug Delivery Science and Technology
Verified
Journal Article
Closed access
DNDiksha Nagpal
Diksha Nagpal
Ravinder VermaRavinder Verma
Ravinder Verma
VMVineet Mittal
Vineet Mittal
PJPhilippe Jeandet
Philippe Jeandet
DKDeepak Kaushik
Deepak Kaushik

2 September 2025 in Antioxidants
Verified
Journal Article
Open access
PDF file
DNDiksha Nagpal
Diksha Nagpal
SNShivangi Neema
Shivangi Neema
SNShakti Nagpal
Shakti Nagpal
MPMurali Pandey
Murali Pandey
DKDeepak Kaushik
Deepak Kaushik
HKHimanshu Kathuria
Himanshu Kathuria
Neurodegenerative diseases are associated with the senescence of functional neurons, which hampers brain functions. These diseases are caused by the accumulation of reactive oxygen species, reactive nitrogen species, cholinesterase malfunction, neuronal inflammation, and mitochondrial dysfunction. The incidence of neurodegenerative disease has been on the rise. Current therapeutic interventions are expensive, exhibit poor efficacy, and have numerous side effects. Several studies have explored the potential of crucial dietary substances rich in antioxidants and micronutrients in alleviating the clinical manifestations of such deadly diseases. Consumption of sufficient antioxidants, fatty acids, and polyphenols in regular diets delays the onset of neurodegenerative diseases. Several medicinal plants, such as Withania somnifera, Curcuma longa, Panax ginseng, Ginkgo biloba, aloe vera, Punica granatum, and various phytoextracts, contain such micronutrients in reasonable amounts. Specific dietary interventions, supplements, and patterns such as the Mediterranean-DASH intervention for neurodegenerative delay, ketogenic, paleolithic, and Wahls elimination diets have been beneficial in neurodegenerative conditions. These diet interventions and other functional foods can be an attractive, non-invasive, and inexpensive approach in the management and prevention of neurodegenerative conditions. This review discusses potential pharmacological bases involved in neurodegeneration, covering mitochondrial damage, impaired mitophagy, neuroinflammation, ferroptosis, glymphatic clearance dysfunction, brain–body interactions, and disruption of vagus nerve stimulation. The review further highlights clinical diet interventions and assorted functional foods, including fruits, vegetables, vitamins, specific supplements, and special diets, for neurodegenerative conditions. The discussion extends insights into clinical research and trials of these functional foods under neurodegenerative conditions. Overall, dietary interventions show promise in the prevention and management of neurodegenerative conditions.

5 September 2022 in Environmental Science and Pollution Research
Verified
Journal Article
Closed access
PDF file
DNDiksha Nagpal
Diksha Nagpal
SNShakti Nagpal
Shakti Nagpal
DKDeepak Kaushik
Deepak Kaushik
HKHimanshu Kathuria
Himanshu Kathuria

30 September 2026 in Macromol
Verified
Journal Article
Open access
PDF file
DNDiksha Nagpal
Diksha Nagpal
SNShakti Nagpal
Shakti Nagpal
HKHimanshu Kathuria
Himanshu Kathuria
MPMurali Pandey
Murali Pandey
VMVineet Mittal
Vineet Mittal
DKDeepak Kaushik
Deepak Kaushik
Background: Taxanes have been a cornerstone in the management of a wide range of cancers, including ovarian, breast, and lung cancer, owing to their microtubule-stabilizing mechanism. Despite their clinical success, their therapeutic utility remains constrained by poor aqueous solubility, a need for toxic solubilizing vehicles, unpredictable pharmacokinetics, and systemic toxicity. Nanomedicine has redefined chemotherapeutic delivery paradigms, with liposomal systems emerging as leading platforms due to their safety and scalability. Purpose: This review aims to critically evaluate the physicochemical and formulation barriers that have limited the successful development of taxane-loaded nanoformulations and to highlight how model-informed principles can be leveraged to improve drug retention, stability, and translational potential. Review Scope: Early liposomal systems faced challenges, including premature drug release and rapid carrier opsonization, limitations that are particularly relevant for compounds with unfavorable biopharmaceutical properties. For taxanes such as paclitaxel, strong partitioning into the lipid bilayer can result in membrane destabilization and premature leakage. Conventional passive loading approaches have shown limited success for these molecules, prompting exploration of active loading strategies. Remote loading utilizes transmembrane gradients to improve drug retention and loading efficiency by concentrating therapeutics within the liposomal core; however, the non-ionizable nature of taxanes restricts the applicability of this approach. Conclusions: These limitations highlight the need for a rational nanocarrier design focused on drug–lipid interactions, physicochemical optimization, surface engineering, controlled release, manufacturing feasibility, and regulatory considerations. Integrating these principles may facilitate the development of robust, scalable, and clinically relevant taxane liposomal formulations, supporting the effective translation of these natural-product-derived therapeutics into improved cancer treatment strategies.